Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Saliba M, Mohanty AS, Ho AL, Drilon A, Dogan S. Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features. Head Neck Pathol. 2022;16(2):612-620.

Sattler SS, Magro CM, Shapiro L, Merves JF, Levy R, Veenstra J, et al. Gastrointestinal Kohlmeier-Degos disease: a narrative review. Orphanet J Rare Dis. 2022;17(1):172.

Cambuli F, Foletto V, Alaimo A, De Felice D, Gandolfi F, Palumbieri MD, et al. Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence. EMBO Rep. 2022;23(5):e54049.

Kim SH, Roytman M, Madera G, Magge RS, Liechty B, Ramakrishna R, et al. Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET/MRI analysis in patients with meningioma. Sci Rep. 2022;12(1):9256.

Amador C, Bouska A, Wright G, Weisenburger DD, Feldman AL, Greiner TC, et al. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice. J Clin Oncol. 2022;40(36):4261-4275.

Wanna-Udom S, Luesiripong C, Sakunrangsit N, Metheepakornchai P, Intharamonthian S, Svasti S, et al. High phosphate intake induces bone loss in nephrectomized thalassemic mice. PLoS One. 2022;17(5):e0268732.

Liu J, Westblade LF, Wang F, Chadburn A, Fideli R, Craney A, et al. Distinct Laboratory Test Result Profiles Between SARS-CoV-2 and Seasonable Influenza Infected Patients. Ann Clin Lab Sci. 2022;52(6):871-879.

Boyraz B, Ly A. Discerning subsets of breast cancer with very low and absent HER2 protein expression. Hum Pathol. 2022;127:50-55.

Larsson PF, Karlsson R, Sarwar M, Miftakhova R, Wang T, Khaja AS, et al. FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer. Mol Oncol. 2022;16(13):2496-2517.

Snyder EL, Wheeler AP, Refaai M, Cohn CS, Poisson J, Fontaine M, et al. Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components. Transfusion. 2022;62(7):1365-1376.